Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-20-001123
Date:2020-02-10
Issuer: CONSTELLATION PHARMACEUTICALS INC (CNST)
Original Submission Date:

Reporting Person:

REEVE EMMA
C/O CONSTELLATION PHARMACEUTICALS, INC.
215 FIRST STREET, SUITE 200 CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-10 M 200 a $7.60 200 direct
COMMON STOCK 2020-02-10 S 200 d $35.00 0 direct
COMMON STOCK 2020-02-11 M 7,212 a $7.60 7,212 direct
COMMON STOCK 2020-02-11 S 7,212 d $35.04 0 direct
COMMON STOCK 2020-02-11 M 1,430 a $8.04 1,430 direct
COMMON STOCK 2020-02-11 S 1,430 d $35.04 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 7.6 2020-02-10 deemed execution date M 200 (d) 2028-03-05 common stock 200 $7.60 28,412 direct
STOCK OPTION (RIGHT TO BUY) 8.04 2020-02-11 deemed execution date M 1,430 (d) 2028-04-22 common stock 1,430 $8.04 36,266 direct
STOCK OPTION (RIGHT TO BUY) 7.6 2020-02-11 deemed execution date M 7,212 (d) 2028-03-05 common stock 7,212 $7.60 21,200 direct
Footnotes
IDfootnote
f1 this transaction was executed in multiple trades at prices ranging from $35.00 to $35.095. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this option was granted on march 6, 2018. the shares underlying the option are scheduled to vest in equal quarterly installments through december 6, 2021.
f3 this option was granted on april 23, 2018. the shares underlying the option are scheduled to vest in equal quarterly installments through october 23, 2021.
WhaleWisdom Logo

Elevate your investments